Aarhus University, Department for Public Health, Section for Sport Science
Aarhus, 8000, Denmark
NCT Number: NCT04864769
Purpose: To examine the absorption of three different protein sources: hydrolyzed krill protein isolate, whey protein isolate, and soy protein isolate.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Aarhus, 8000, Denmark
Design and Method: Randomized, controlled, double-blind cross-study, in which 12 healthy adult young men in randomized order ingest 35 g of protein of crude protein from one of the three protein sources or water on four different experimental days. Before and up to three hours after ingestion of the test beverage, blood samples are collected for 8 time points during each experimental day.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ingestion of 35 g Krill protein hydrolysate
Ingestion of 35 g Soy protein isolate
Ingestion of 35 g Whey protein isolate
Ingestion of water (control)
Time frame: 10 minutes prior to supplement up to 180 minutes after supplement
Measurement of changes in amino acids concentrations in the blood
Time frame: 10 minutes prior to supplement up to 180 minutes after supplement
Measurements of changes in Hunger and satiety using 100 mm Visual Analogue Scores
Time frame: 10 minutes prior to supplement up to 180 minutes after supplement
Changes in serum insulin
Mette Hansen
Other
Effect of Intake of Hydrolyzed Krill Protein Isolate, Whey Protein Isolate and Soy Protein Isolate on Plasma Amino Acid Profile
Acronym: KRILL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07618663
Diabetes Mellitus, Endocrine System Diseases
Lahore, Shaikhupura, Pakistan
View Trial DetailsNCT05259449
Diabetes Mellitus, Diabetes Mellitus, Type 2
Puerto Real, Cadiz, Spain
View Trial DetailsNCT00445627
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT05268042
Body Weight, Digestive System Diseases
Birmingham, Alabama, United States
View Trial Details